Ceftriaxone and Doxycycline Combination Therapy

Guideline-Supported Combination Regimens

The Centers for Disease Control and Prevention (CDC) recommends ceftriaxone 250 mg IM PLUS either azithromycin 1 g orally OR doxycycline 100 mg orally twice daily for 7 days as standard treatment for uncomplicated gonococcal infections of the cervix, urethra, rectum, and pharynx 1
The CDC recommends cefoxitin 2 g IM (or ceftriaxone 250 mg IM) PLUS doxycycline 100 mg orally twice daily for 10-14 days for outpatient management of Pelvic Inflammatory Disease (PID) 2
For acute disseminated Lyme disease, both oral doxycycline alone and IV ceftriaxone alone are equally effective, with a randomized trial of 140 patients showing 88% cure with doxycycline versus 85% with ceftriaxone 5

There are no documented pharmacokinetic or pharmacodynamic interactions between ceftriaxone and doxycycline that would contraindicate their concurrent use 5
The main concern with ceftriaxone is increased diarrhea risk, with one study showing a 4-fold increase in diarrhea frequency with ceftriaxone 5

Combination regimens (ceftriaxone with doxycycline, azithromycin, or other antibiotics) may be more effective than monotherapy, particularly for pharyngeal infections, showing persistent infection in only 1.8% versus 5.8% with ceftriaxone alone 3, 4
Doxycycline provides definitive coverage for chlamydial infections when used in combination with cephalosporins 2

Do not omit doxycycline when treating gonorrhea, as presumptive treatment for concurrent chlamydial infection is essential given high co-infection rates 1
Ensure adequate duration of doxycycline therapy, typically 7-14 days depending on the indication, not just a single dose 1, 2
For pharyngeal gonorrhea specifically, combination therapy is preferred over monotherapy given lower cure rates at this anatomic site 3, 4
Doxycycline is contraindicated in pregnancy and children ≤17 years, so alternative regimens should be used in these populations 6